Dept Ophthalmology, Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
NCT Number: NCT00742950
The investigators' purpose is to study the induced refractive change caused by different 2.8-mm corneal incision locations in phacoemulsification, because the investigators hypothesize that the effect may be different for nasal, temporal, and superior location, although they are considered astigmatism neutral.
Patients will be randomized to nasal or temporal incision, or assigned to superior incision, depending on preexisting astigmatism. Visual acuity, refraction, keratometry, Pentacam analysis, intraocular pressure, biomicroscopy, and funduscopy, will be carried out before and after phacoemulsification.
Outcome measures will be induced corneal refractive change (Fourier power vector analysis), ISV change, and visual acuity, at 6 months.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Not applicable
Madrid, 28034, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Phacoemulsification through a nasal 2.8-mm incision
Other names: Phacoemulsification nasal incision
Phacoemulsification through a 2.8-mm temporal incision
Other names: Phacoemulsification temporal incision
Phacoemulsification through a superior 2.8-mm corneal incision
Other names: Phacoemulsification superior incision
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Hospital Universitario Ramon y Cajal
Other
Study of Refractive Change Induced by 2.8-mm Corneal Incisions for Cataract Surgery
Acronym: CINPHA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06399211
Aphakia, Aphakia, Postcataract
View Trial DetailsNCT06250855
Astigmatism, Cataract
Bacau, Romania
View Trial DetailsNCT07176897
Astigmatism, Cataract
Encino, California, United States
View Trial DetailsNCT04676451
Astigmatism, Cataract
Hershey, Pennsylvania, United States
View Trial Details